Predictive Oncology Inc. (POAI) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 127 transactions totaling $182.2K, demonstrating a bullish sentiment with $120.4K in net insider flow. The most recent transaction on Nov 28, 2025 involved a transaction of 2,373 shares valued at $14.0K.
No significant insider buying has been recorded for POAI in the recent period.
No significant insider selling has been recorded for POAI in the recent period.
Based on recent SEC filings, insider sentiment for POAI is bullish with an Insider Alignment Score of 83/100 and a net flow of $120.4K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Predictive Oncology Inc. (POAI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading POAI stock, having executed 127 transactions in the past 90 days. The most active insider is Carl I. Schwartz (Executive), who has made 6 transactions totaling $2.5M.
Get notified when executives and directors at POAI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | F. Vennare Raymond | Executive | Payment | 2,373 | $5.90 | $14.0K | |
| Sep 9, 2025 | F. Vennare Raymond | Executive | Award | 124,959 | $N/A | $0 | |
| Sep 9, 2025 | Blacher Joshua | Executive | Award | 97,000 | $N/A | $0 | |
| Sep 9, 2025 | Lee Nuzum Charles Sr | Executive | Award | 64,680 | $N/A | $0 | |
| Sep 9, 2025 | Gregory St. Clair Sr | Executive | Award | 64,680 | $N/A | $0 | |
| Sep 9, 2025 | Rao Veena | Executive | Award | 64,680 | $N/A | $0 | |
| Sep 9, 2025 | Hawryluk Matthew | Executive | Award | 64,680 | $N/A | $0 | |
| Sep 9, 2025 | E. Handley Daniel | Executive | Award | 64,680 | $N/A | $0 | |
| Sep 9, 2025 | Chung-welch Nancy | Executive | Award | 64,680 | $N/A | $0 | |
| Apr 5, 2024 | Chung-welch Nancy | Executive | Award | 2,353 | $N/A | $0 | |
| Apr 5, 2024 | E. Handley Daniel | Executive | Award | 2,353 | $N/A | $0 | |
| Apr 5, 2024 | Lee Nuzum Charles Sr | Executive | Award | 3,268 | $N/A | $0 | |
| Apr 5, 2024 | Rao Veena | Executive | Award | 3,268 | $N/A | $0 | |
| Apr 5, 2024 | Hawryluk Matthew | Executive | Award | 2,368 | $N/A | $0 | |
| Apr 5, 2024 | Gregory St. Clair Sr | Executive | Award | 3,268 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 99 | $2.3M | 85.6% |
Purchase(P) | 16 | $151.3K | 5.5% |
Other(J) | 2 | $143.6K | 5.3% |
Exercise(M) | 3 | $37.7K | 1.4% |
Sale(S) | 2 | $30.9K | 1.1% |
Payment(F) | 3 | $19.5K | 0.7% |
Disposition(D) | 1 | $11.5K | 0.4% |
Conversion(C) | 1 | $0 | 0.0% |
Insiders at Predictive Oncology Inc. are accumulating shares at an accelerated pace. With 16 insiders making 127 transactions totaling $151.3K in purchases versus $30.9K in sales, the net buying activity of $120.4K signals strong executive confidence. Carl I. Schwartz (Executive) leads the buying activity with $2.5M in transactions across all time.